Acromegaly resistant
Showing 1 - 25 of 5,507
Genetic Studies of Insulin and Diabetes
Recruiting
- Diabetes Mellitus
- Severe Insulin Resistance
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 26, 2023
Fibrosis Trial in Aarhus (Growth hormone, saline and GH receptor blockade (Pegvisomant))
Recruiting
- Fibrosis
- Growth hormone, saline and GH receptor blockade (Pegvisomant)
-
Aarhus, DenmarkAarhus University
Aug 31, 2021
Somatostatin Receptors and GH Receptor Expression on Bone of
Completed
- Evaluation of the Expression of Somatostatin Receptors and GH Receptor on Bone of Acromegalic Patients
- Trans-sphenoidal surgery
-
Roma, ItalyFondazione Policlinnico Gemelli IRCCS
Apr 6, 2023
Acromegaly Due to Pituitary Adenoma Trial in Copenhagen (GIP-A, Placebo)
Recruiting
- Acromegaly Due to Pituitary Adenoma
- GIP-A
- Placebo
-
Copenhagen, DenmarkDepartment of Biomedical Sciences
Nov 1, 2022
(RWS) of Lanreotide Autogel for Treatment of Acromegaly in China
Recruiting
- Acromegaly
-
Beijing, China
- +11 more
Jul 13, 2022
Therapies in Acromegaly Disease: Acral Morpho-functional Study
Recruiting
- Acromegaly
- Medical surgery therapy
-
Milano, ItalyIstituto Auxologico Italiano IRCCS San Luca
Jul 25, 2023
Acromegaly Trial in Los Angeles (Pegvisomant, Octreotide LAR, Lanreotide)
Terminated
- Acromegaly
- Pegvisomant
- +2 more
-
Los Angeles, CaliforniaCedars-Sinai Medical Center
Dec 12, 2022
Acromegaly, GEP-NET Trial in Worldwide (Debio 4126, Sandostatin LAR, Somatuline ATG)
Recruiting
- Acromegaly
- GEP-NET
- Debio 4126
- +2 more
-
Copenaghen, Denmark
- +34 more
Jan 27, 2023
Acromegaly Trial (Diet)
Not yet recruiting
- Acromegaly
- Diet
- (no location specified)
Jul 18, 2022
Acromegaly Trial in Worldwide (CAM2029 (octreotide subcutaneous depot), Matching )
Active, not recruiting
- Acromegaly
- CAM2029 (octreotide subcutaneous depot)
- Matching placebo
-
Los Angeles, California
- +62 more
Dec 9, 2022
PegvisOMant and the Immune SystEm (PROMISE)
Active, not recruiting
- Acromegaly
-
Rome, ItalyDepartment of Experimental Medicine, "Sapienza" University of Ro
Nov 6, 2022
Acromegaly: Balance, Falls and Fracture Risk
Not yet recruiting
- Acromegaly
- HR-pQCT
- +7 more
-
Aalborg, North Denmark Region, DenmarkAalborg University Hospital
Mar 3, 2023
Satisfaction With Somatostatin Analogue Injections in Acromegaly
Not yet recruiting
- Acromegaly
- (no location specified)
Aug 9, 2022
A Prospective Study of Outcome After Therapy for Acromegaly
Active, not recruiting
- Acromegaly
- Surgery for acromegaly
- +3 more
-
New York, New YorkNeuroendocrine Unit; Columbia University Medical Center, 180 For
Oct 24, 2022
Acromegaly: A Pattern of Treatment and Comparative Effectiveness
Recruiting
- Acromegaly
- Transnasal butterfly surgery
- +2 more
-
Guangzhou, Guangdong, ChinaChina Acromegaly Organization
Mar 14, 2022
Acromegaly Trial in Novara (Usual clinical practice + hypoproteic diet)
Not yet recruiting
- Acromegaly
- Usual clinical practice + hypoproteic diet
-
Novara, Italy: Italy Pediatric Endocrine Service of AOU Maggiore della Carità
Mar 26, 2022
Carbapenem-Resistant Enterobacteriaceae, Vancomycin (Glycopeptide) Resistant Enterococcus (VRE) Trial in Chuncheon, Seoul (fecal
Not yet recruiting
- Carbapenem-Resistant Enterobacteriaceae
- Vancomycin (Glycopeptide) Resistant Enterococcus (VRE)
- fecal microbiota transplantation
-
Chuncheon, Gangwon-do, Korea, Republic of
- +1 more
Aug 18, 2023
Ovarian Cancer Recurrent Trial (Fluzopril Combined With Apatinib)
Not yet recruiting
- Ovarian Cancer Recurrent
- Fluzopril Combined With Apatinib
- (no location specified)
Oct 22, 2023
Pulmonary Tuberculosis Trial in Rio de Janeiro, Rio De Janeiro (Standard care plus pulmonary rehabilitation, Standard Care)
Recruiting
- Pulmonary Tuberculosis
- Standard care plus pulmonary rehabilitation
- Standard Care
-
Rio de Janeiro, Brazil
- +1 more
Nov 7, 2023
Platinum-resistant Ovarian Cancer
Not yet recruiting
- Ovarian Cancer
- pegylated liposomal doxorubicin
- (no location specified)
Aug 2, 2023